JPRN-UMIN000035287
Completed
Phase 2
Phase II study of hypofractionated postoperative intensity-modulated radiotherapy for prostate cancer in adjuvant and salvage settings - Phase II study of hypofractionated postoperative intensity-modulated radiotherapy for prostate cancer in adjuvant and salvage settings
ConditionsProstate cancer
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- The University of Tokyo
- Enrollment
- 55
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a) patient refused to participate in this trial b) distant metastasis is recognized c) past history of irradiation to pelvis d) participation in another clinical trial which may affect this trial e) judged as inappropriate to participation by investigators
Investigators
Similar Trials
Recruiting
Phase 2
Postoperative hypofractionation and simultaneous integrated boost with or without regional nodal irradiation by TomoTherapy for breast cancerBreast cancer patients after breast conserving surgery with or without adjuvant chemotherapybreast cancerhypofractionationsimultaneous integrated boostTomoTherapyTCTR20210623004/A48
Not yet recruiting
Not Applicable
Comparing Conventional and Hypofractionated Radiation Therapy with Chemotherapy After Cervical Cancer Surgery: A Prospective Multicenter Phase 3 StudyNeoplasmsKCT0009607Samsung Medical Center284
Recruiting
Not Applicable
Postoperative hypofractionated intensity-modulated radiotherapy endometrial cancerKCT0008050Samsung Medical Center92
Recruiting
Not Applicable
Postoperative intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer trialKCT0004702Samsung Medical Center84
Recruiting
Not Applicable
Postoperative intensity-modulated radiation therapy in cervical cancer trialKCT0004700Samsung Medical Center120